At Profound Research, we believe that our strength lies in our people. Today, we're excited to spotlight an exceptional team member whose work embodies our commitment to transforming clinical research. Michelle Peek brings nearly three decades of hands-on experience and a passion for innovation that has consistently pushed the boundaries of site development. Her career is a testament to dedication, precision, and the drive to bring advanced treatments to patients faster. In this in-depth Q&A, Michelle shares her journey, the strategies she employs to streamline site operations, and her vision for the future—all of which highlight how one individual's efforts can catalyze significant industry change. 

Can you share a bit about your journey in clinical research and what led you to your role as Senior Director of Site Development at Profound Research?   

"My journey in clinical research began 29 years ago as a study coordinator in an internal medicine practice, where I led trials focused on senior patients. I later transitioned into cardiology research, where I managed both inpatient and outpatient trials. My experience expanded as I served as a site manager for a leading cardiologist, overseeing studies that involved close coordination with local IRBs, pharmacy teams, and RNs. I was fortunate to be involved in critical phases of patient care—from the ER to the cardiac catheterization lab—ensuring smooth protocol execution for groundbreaking medications like Plavix and Eliquis. My role as a Site Director allowed me to lead high-volume vaccine trials and even establish our own PBMC lab, which significantly enhanced our research capabilities. After building a robust vaccine research network at Elligo Health Research, I joined Profound Research in 2023 as Senior Director of Site Development and Training. Here, I bring all that experience to support site development, mentor emerging talent, and drive the day-to-day success of our clinical operations." 

How does your work in site development contribute to expanding access to innovative treatments for patients? 

"Ensuring that clinical sites are equipped with the right infrastructure and trained personnel is key to launching and managing trials effectively. By optimizing site readiness, we can accelerate the start of clinical studies and bring cutting-edge treatments to patients faster. This focus on operational excellence directly supports our mission to expand access to innovative therapies." 

One of our core values is ‘Urgency’—acting swiftly and decisively to meet the needs of patients, partners, and colleagues. How do you approach this in your role when developing and expanding sites? 

"I believe every day counts for patients waiting for new therapies. My approach is all about streamlining site activation, reducing operational bottlenecks, and ensuring our teams are fully equipped to launch studies efficiently. This blend of speed and precision means we can deliver potentially life-changing treatments to patients sooner, reflecting our commitment to acting with urgency." 

Building strong patient-physician relationships is central to our mission. How does site development play a role in ensuring that clinical research enhances, rather than disrupts, that relationship?  

"Effective site development is about people as much as it is about processes. I work closely with physicians to onboard new investigators and integrate clinical research seamlessly into their practices. By serving as a liaison between physicians and our internal teams, I help foster trust and collaboration, ensuring that the research process supports and even enhances patient-physician relationships." 

What excites you most about the future of site development at Profound Research, and how do you see our commitment to excellence shaping the next phase of growth?   

"I'm particularly excited about expanding our research footprint into new geographic regions, especially in areas that have historically had limited access to clinical trials. Our commitment to excellence means that as we grow, we will continue to uphold the highest standards in patient care, research quality, and operational efficiency. This focus not only fuels our growth but also solidifies our position as a disruptor in the industry." 

When you’re not working to expand clinical research sites, how do you like to spend your free time? Any hobbies or interests you’re passionate about? 

"Outside of work, I love spending quality time with my family and our dogs. I also enjoy long walks on the beach, which help me recharge and find peace." 

In Conclusion 

Michelle Peek’s journey and vision exemplify the spirit of innovation and excellence at Profound Research. Her dedication to streamlining clinical trials and building strong relationships within the research community plays a vital role in bringing advanced therapies to patients faster, ensuring a brighter future for clinical research. 

Thank you, Michelle, for your commitment to excellence and for being such an integral part of the Profound Research family!